Transcripts

Karyopharm Therapeutics (KPTI) earnings call transcripts

Earnings call transcripts for Karyopharm Therapeutics Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter around an August myelofibrosis filing, while acknowledging financing needs and narrowing investment after endometrial cancer results.

    Aug 13, 2026Mildly positive0.25